InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,185.20
(
0.09%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.22
(
0.11%
)
Bitcoin
65,936.58
(
-1.05%
)
Post# of 252220
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cooldrinkh2o

Send PM Follow Ignore
Followers 0
Posts 113
Boards Moderated 0
Alias Born 05/28/2005

cooldrinkh2o

Re: masterlongevity post# 136450

Friday, 02/03/2012 8:05:13 PM

Friday, February 03, 2012 8:05:13 PM

Post# of 252220
Lapatinib in combination with Let (AI in EU) in ER+/HER2+ mBC.....the overall trial was negative. The caveat is PFS in the pre specified subset was the primary endpoint of the study.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up